These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 200987)
21. [Evaluation of Bordetella strains used in the production of anti-pertussis vaccine in stationary culture]. Castillejos Carmona R; González Pacheco M Salud Publica Mex; 1981; 23(6):549-53. PubMed ID: 6278653 [No Abstract] [Full Text] [Related]
22. Pertussis vaccination and whooping cough: and now what? Guiso N Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131 [TBL] [Abstract][Full Text] [Related]
23. [Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form]. Siniashina LN; Siniashina LS; Semin EG; Amelina IP; Karataev GI Mol Gen Mikrobiol Virusol; 2010; (3):31-6. PubMed ID: 20886687 [TBL] [Abstract][Full Text] [Related]
24. Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium. Idigbe EO; Parton R; Wardlaw AC J Med Microbiol; 1981 Nov; 14(4):409-18. PubMed ID: 6273564 [TBL] [Abstract][Full Text] [Related]
25. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. Bouchez V; Guiso N Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280 [TBL] [Abstract][Full Text] [Related]
26. [Pertussis vaccines: acellular versus whole cell. Perhaps a return to the past?]. Cofré J Rev Chilena Infectol; 2015 Oct; 32(5):559-63. PubMed ID: 26633113 [TBL] [Abstract][Full Text] [Related]
27. A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines. Steinhoff MC; Reed GF; Decker MD; Edwards KM; Englund JA; Pichichero ME; Rennels MB; Anderson EL; Deloria MA; Meade BD Pediatrics; 1995 Sep; 96(3 Pt 2):567-70. PubMed ID: 7659477 [TBL] [Abstract][Full Text] [Related]
28. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
29. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis. Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216 [TBL] [Abstract][Full Text] [Related]
30. The possible adjuvant role of bordetella pertussis and pertussis vaccine in causing severe encephalopathic illness: a presentation of three case histories. Cavanagh NP; Brett EM; Marshall WC; Wilson J Neuropediatrics; 1981 Nov; 12(4):374-81. PubMed ID: 6278350 [TBL] [Abstract][Full Text] [Related]
32. [Improved technology of culturing Bordetella pertussis based on a study of the kinetics of the process]. Miriasova LV; Basnak'ian IA Zh Mikrobiol Epidemiol Immunobiol; 1983 Oct; (10):20-5. PubMed ID: 6318479 [TBL] [Abstract][Full Text] [Related]
33. [Cultivation of Bordetella pertussis in liquid semisynthetic nutrient media with ion-exchange resins]. Sukhinova EE; Shmeleva EI; Mertsalova NU; Iulin II; Golshmid VK Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):64-7. PubMed ID: 6277111 [TBL] [Abstract][Full Text] [Related]
35. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705 [TBL] [Abstract][Full Text] [Related]
36. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection. Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570 [TBL] [Abstract][Full Text] [Related]
37. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines. Cameron J Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430 [No Abstract] [Full Text] [Related]
38. PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease. Streefland M; van de Waterbeemd B; Happé H; van der Pol LA; Beuvery EC; Tramper J; Martens DE Vaccine; 2007 Apr; 25(16):2994-3000. PubMed ID: 17313999 [TBL] [Abstract][Full Text] [Related]
39. History of the development of pertussis vaccine. Pittman M Dev Biol Stand; 1991; 73():13-29. PubMed ID: 1778306 [TBL] [Abstract][Full Text] [Related]
40. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines. Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]